Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Authors
Keywords
Oncolytic viruses, Coxsackievirus A21, Plasmacytoid DC, Innate immunity, Adaptive immunity
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-02
DOI
10.1186/s40425-019-0632-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new therapeutic target: the CD69-Myl9 system in immune responses
- (2019) Motoko Y. Kimura et al. Seminars in Immunopathology
- Oncolytic Viruses for Multiple Myeloma Therapy
- (2018) Christine Calton et al. Cancers
- High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer
- (2017) Yusuke Okuma et al. LUNG CANCER
- Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
- (2017) Namit Holay et al. Frontiers in Immunology
- UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells
- (2016) Ismael Samudio et al. BLOOD
- Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
- (2016) A. Stiff et al. MOLECULAR CANCER THERAPEUTICS
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cellsin vivo
- (2015) Y. M. El-Sherbiny et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- (2015) D. M. S. Hossain et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma
- (2015) Katarina Mirjačić Martinović et al. JOURNAL OF CLINICAL PATHOLOGY
- Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
- (2015) C Parrish et al. LEUKEMIA
- A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib
- (2014) A Ray et al. LEUKEMIA
- Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
- (2013) V.A. Jennings et al. INTERNATIONAL JOURNAL OF CANCER
- NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2
- (2013) Todd A Braciak et al. Journal of Translational Medicine
- BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis
- (2013) Sara Samuel et al. MOLECULAR THERAPY
- Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine
- (2013) Yushi Yao et al. PLoS One
- Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
- (2012) Katie Twigger et al. BMC CANCER
- Interferon-Alpha in the Treatment of Multiple Myeloma
- (2012) Khoo CURRENT DRUG TARGETS
- Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
- (2012) Robert A. Adair et al. INTERNATIONAL JOURNAL OF CANCER
- Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro
- (2012) Gerard J. Madlambayan et al. LEUKEMIA RESEARCH
- Interferon-α in acute myeloid leukemia: an old drug revisited
- (2011) S Anguille et al. LEUKEMIA
- Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappaB mediated and supports innate and adaptive anti-tumour immune priming
- (2011) Lynette Steele et al. Molecular Cancer
- Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
- (2011) Gough G Au et al. Virology Journal
- Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
- (2010) Heather MacTavish et al. PLoS One
- Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
- (2009) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
- (2009) E J Ilett et al. GENE THERAPY
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
- (2008) L. Vidal et al. CLINICAL CANCER RESEARCH
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started